share_log

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket

為什麼石墨生物股票的交易價格較低 50%;這裡有 20 隻股票在市場前移動
Benzinga Real-time News ·  2023/01/06 08:03
Gainers
漲幅
OncoCyte Corporation (NASDAQ:OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets. Spruce Biosciences, Inc. (NASDAQ:SPRB) shares rose 84% to $2.30 in pre-market trading. Spruce Biosciences and Kaken Pharmaceutical reported an exclusive licensing agreement to develop and commercialize Tildacerfont for CAH in Japan. CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 70.4% to $3.05 in pre-market trading. CytomX and Moderna reported a strategic research collaboration for mRNA-based conditionally activated therapeutics. AMTD Digital Inc. (NYSE:HKD) shares rose 40.2% to $42.00 in pre-market trading...
科技股份有限公 (納斯達克:OCX) 在盤前交易中上漲 89.2%,至 0.70 美元。Ancocyte, 上個月, 宣布超過 40% 減少其勞動力重新調整團隊朝著解決更大市場的關鍵產品. 雲杉生...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論